Search Within

Brett C Wegner

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (4)
  2. Department of Medicine (4)
  3. Hematologic Malignancies, Division of (4)
  4. Lymphoma (4)
  5. Population Sciences Research Program (4)
  6. Dermatology (2)

More Groups

People
  1. David Straus (4)
  2. Steven Horwitz (4)
  3. Patricia Myskowski (2)
  4. Andrew Zelenetz (1)
  5. Ariela Noy (1)
  6. Carol Portlock (1)

More People

Years
  1. 2014 (1)
  2. 2011 (1)
  3. 2010 (1)
  4. 2005 (1)
Publications
  1. Blood (2)
  2. Annals of Oncology (1)
  3. Journal of Clinical Oncology (1)
Publishers
  1. American Society of Hematology (2)
  2. American Society of Clinical Oncology (1)
  3. Oxford University Press (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of phase II trial of doxorubicin HCI liposome injection followed by bexarotene in advanced cutaneous T-cell lymphoma
    Journal Article

    Straus, D. J.; Duvic, M.; Horwitz, S. M.; Hymes, K.; Goy, A.; Hernandez-Ilizaliturri, F. J.; Feldman, T.; Wegner, B.; Myskowski, P. L.
    Annals of Oncology (2014)

    Fulltext@MSK | Save
  • Final results of phase II trial of pegylated liposomal doxorubicin (PLD) followed by bexarotene (Bex) in advanced cutaneous T-cell lymphoma (CTCL)
    Meeting Abstract

    Straus, D. J.; Duvic, M.; Horwitz, S. M.; Hymes, K. B.; Goy, A.; Hernandez-Ilizaliturri, F. J.; Feldman, T.; Wegner, B.; Myskowski, P.
    Blood (2011)

    Fulltext@MSK | Save
  • Interim results of phase II trial of pegylated liposomal doxorubicin (PLD) followed by bexarotene in advanced cutaneous T-cell lymphoma (CTCL)
    Meeting Abstract

    Straus, D. J.; Duvic, M.; Horwitz, S. M.; Hymes, K. B.; Goy, A.; Hernandez-Ilizaliturri, F. J.; Feldman, T.; Wegner, B.; Myskowski, P.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Early safety and efficacy analysis of a phase II study of sequential R-CHOP and Yttrium-90 ibritumomab tiuxetan (Zevalin((R))) for elderly high risk patients with untreated DLBCL
    Meeting Abstract

    Hamlin, P. A.; Moskowitz, C. H.; Wegner, B. C.; Portlock, C. S.; Straus, D. J.; Noy, A.; Dumitrescu, O.; Palomba, M. L.; Horwitz, S. M.; O'Connor, O. A.; more...
    Blood (2005)

    Fulltext@MSK | Save